At a glance
ClinicalIndex Comparison RecordN/ACompleted· 61 enrolled
Drug / intervention
Transcranial ExAblatedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
In Brief
A clinical study evaluating Transcranial ExAblate for Essential Tremor. Completed, enrolled 61 participants across 7 sites.
Detailed Summary
The objective of this prospective, multi site, single-arm study is to capture the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in patients with essential tremor (ET).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEssential Tremor
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 2014
Enrollment StartApr 2015
Primary CompletionFeb 2022
Study CompletionMar 2023
TodayJul 2026
First PostedNov 13, 2014
Enrollment StartApr 1, 2015
Primary CompletionFeb 18, 2022
Study CompletionMar 10, 2023
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 11.6 years ago
Interventions
Transcranial ExAblatedevice
Transcranial ExAblate